BANK OF AMERICA CORP /DE/
BankPosition in LKFT — Lakefront Biotherapeutics NV
CIK 70858
CHARLOTTE, NC
Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$225,719
-$396,031 QoQ
Shares Held
7,529
-63.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 78 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,049,938,280 across 338 Biotechnology names. LKFT ranks #279 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in LKFT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $225,719 | 7,529 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $621,750 | 20,725 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,012,685 | 30,969 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,072,072 | 30,949 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $848,263 | 30,306 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,497,301 | 59,606 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $617,484 | 22,454 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $540,387 | 18,770 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $873,816 | 35,263 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $209,106 | 6,494 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $846,007 | 20,812 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $671,892 | 19,447 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $824,745 | 20,284 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $622,219 | 16,103 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $125,728 | 2,833 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $203,775 | 4,779 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $226,826 | 4,065 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $326,719 | 5,268 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,150,731 | 39,012 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $459,967 | 8,743 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $316,136 | 4,589 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,391,549 | 18,051 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,237,248 | 12,500 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,180,161 | 15,363 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,456,851 | 12,453 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,206,916 | 36,785 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||